Allianz Asset Management Gmb H Ascendis Pharma A/S Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 3,967 shares of ASND stock, worth $556,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,967

Previous 3,767 5.31%

Holding current value

$556,570

Previous $513,000 15.4%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$113.0 - $153.43 $22,600 - $30,686	200 Added 5.31%	3,967 $592,000
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $484 - $614	4 Added 0.11%	3,767 $513,000
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $20,122 - $25,982	163 Added 4.53%	3,763 $568,000
Q4 2023 Feb 12, 2024	BUY	$86.1 - $127.36 $309,960 - $458,496	3,600 New	3,600 $453,000
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $1.17 Million - $1.42 Million	11,200 New	11,200 $1.2 Million
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $3.57 Million - $4.74 Million	-34,910 Reduced 65.85%	18,105 $2.12 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $1.19 Million - $1.59 Million	9,355 Added 21.43%	53,015 $7.15 Million
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $3.02 Million - $4.74 Million	26,765 Added 158.42%	43,660 $6.96 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $1.86 Million - $2.23 Million	-15,330 Reduced 47.57%	16,895 $2.22 Million
Q1 2021 May 13, 2021	SELL	$124.92 - $173.33 $280,445 - $389,125	-2,245 Reduced 6.51%	32,225 $4.15 Million
Q3 2020 Nov 13, 2020	SELL	$134.29 - $154.32 $573,418 - $658,946	-4,270 Reduced 11.02%	34,470 $5.32 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $182,381 - $256,636	1,645 Added 4.43%	38,740 $5.73 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $134,358 - $200,977	-1,385 Reduced 3.6%	37,095 $4.18 Million
Q4 2019 Feb 13, 2020	SELL	$91.45 - $139.12 $258,346 - $393,014	-2,825 Reduced 6.84%	38,480 $5.35 Million
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $1.25 Million - $1.55 Million	-13,055 Reduced 24.02%	41,305 $3.98 Million
Q2 2019 Aug 08, 2019	SELL	$107.11 - $132.09 $328,827 - $405,516	-3,070 Reduced 5.35%	54,360 $6.26 Million
Q1 2019 May 13, 2019	BUY	$62.15 - $129.99 $845,861 - $1.77 Million	13,610 Added 31.06%	57,430 $6.76 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $1.89 Million - $2.39 Million	-34,300 Reduced 43.91%	43,820 $2.69 Million
Q3 2018 Nov 13, 2018	SELL	$63.77 - $76.28 $4.42 Million - $5.29 Million	-69,340 Reduced 47.02%	78,120 $5.54 Million
Q2 2018 Aug 13, 2018	SELL	$58.55 - $73.92 $1.83 Million - $2.31 Million	-31,260 Reduced 17.49%	147,460 $9.81 Million
Q1 2018 May 14, 2018	BUY	$38.98 - $68.04 $13,642 - $23,814	350 Added 0.2%	178,720 $11.7 Million
Q4 2017 Feb 13, 2018	BUY	$31.98 - $40.38 $1.85 Million - $2.34 Million	57,920 Added 48.09%	178,370 $7.15 Million
Q3 2017 Nov 13, 2017	BUY	$26.89 - $37.1 $3.24 Million - $4.47 Million	120,450	120,450 $4.37 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.83B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Ascendis Pharma A/S Transaction History